Skip to main content

NextCure, Inc.

For the period ended Mar 31, 2026. Filed May 7, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

NXTC$6.27+17.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

NextCure, Inc.

Form 10-Q

For the Quarter Ended March 31, 2026

TABLE OF CONTENTS

​ · ​
​​Page
PART I. FINANCIAL INFORMATION
Item 1.Financial Statements1
​Condensed Balance Sheets as of March 31, 2026 (unaudited) and December 31, 20251
​Unaudited Condensed Statements of Operations and Comprehensive Loss for the Three Months Ended March 31, 2026 and 20252
​Unaudited Condensed Statements of Stockholders’ Equity for the Three Months Ended March 31, 2026 and 20253
​Unaudited Condensed Statements of Cash Flows for the Three Months Ended March 31, 2026 and 20254
​Notes to Unaudited Condensed Financial Statements5
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations16
Item 3.Quantitative and Qualitative Disclosures about Market Risk25
Item 4.Controls and Procedures25
Part II. OTHER INFORMATION
Item 1.Legal Proceedings25
Item 1A.Risk Factors25
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds25
Item 3.Defaults Upon Senior Securities26
Item 4.Mine Safety Disclosures26
Item 5.Other Information26
Item 6.Exhibits27
SIGNATURES28

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.